Drug Approval | February 26, 2025
Among those identified, 2.4 lakh patients have been notified from public health institutions, while 1.1 lakh were identified through private healthcare facilities
We will continue to expand our range of purified excipients, offering pharmaceutical companies a dependable partner
Krishna Institute of Medical Sciences Ltd enters into agreement with Splendid Hospitals
Richard A. Gonzalez to retire from the board of directors effective July 1, 2025
It will bring together renowned global experts in the field to discuss groundbreaking advances in biomaterials and their clinical applications
EBITDA grew by 11% on a YoY basis to Rs. 296 crore due to improved performance in CDMO Sterile Injectables, CRDMO and Generics
The camp, operational daily from 12 PM to 4 PM, offers free health check-ups, blood pressure monitoring
Expand the scope of the Production-Linked Incentive (PLI) scheme and increase its allocation to cover more pharmaceutical products and raw materials
Subscribe To Our Newsletter & Stay Updated
